Loading company details...
Latest Form 4 (Nov 3, 2026): John M. Leonard (President and CEO): Sale of 9,000 shares, $107.9K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Nov 3, 2026 | John M. Leonard, President and CEO | Sale | 9,000 | $107.9K |
| Oct 28, 2026 | Jing L. Marantz, EVP, Chief Medical Officer | Grant/Award | 199,822 | n/a |
| Oct 6, 2026 | Michael P. Dube, VP, Chief Accounting Officer | Sale | 1,864 | $23.2K |
| Aug 24, 2026 | John M. Leonard, President and CEO | Sale | 19,890 | $250.6K |
| Jul 24, 2026 | Edward J. Dulac III, EVP, Chief Financial Officer | Sale | 8,111 | $91.2K |
| Jul 6, 2026 | Michael P. Dube, VP, Chief Accounting Officer | Sale | 2,641 | $44.3K |
| Jul 6, 2026 | Edward J. Dulac III, EVP, Chief Financial Officer | Sale | 4,677 | $84.2K |
| Jun 10, 2026 | Frank Verwiel | Grant/Award | 9,200 | n/a |
| Jun 10, 2026 | Georgia Keresty | Grant/Award | 9,200 | n/a |
| Jun 10, 2026 | Jesse Goodman | Grant/Award | 9,200 | n/a |